This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Felix Schiele: Innovator in Anticoagulant Antidotes
Introduction
Felix Schiele is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medicine, particularly in the development of antidotes for anticoagulants. His innovative work has the potential to impact patient care and treatment options.
Latest Patents
Felix Schiele holds a patent for his invention related to Dabigatran antidotes. The present invention pertains to antibody molecules against anticoagulants, specifically dabigatran, and their use as antidotes for such anticoagulants. This patent highlights his commitment to advancing medical science and improving therapeutic interventions.
Career Highlights
Felix Schiele is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Joanne Van Ryn and Daniel Seeliger. Their collaboration fosters a dynamic environment for innovation and enhances the potential for successful outcomes in their projects.
Conclusion
Felix Schiele's work in developing antidotes for anticoagulants exemplifies the importance of innovation in medicine. His contributions are paving the way for improved treatment options and better patient outcomes.